Impact of NSAIDs on Colorectal Cancer Rates
Author Information
Author(s): Bryan A Rettig, Henry M Lemon
Primary Institution: Nebraska Department of Health
Hypothesis
The changing gender ratios of colorectal cancer may be influenced by non-steroidal anti-inflammatory drugs (NSAIDs) rather than just contraceptive use or estrogen replacement therapy.
Conclusion
NSAID therapy has been shown to reduce colorectal cancer development and recurrence of polyps, particularly in women.
Supporting Evidence
- NSAIDs have been shown to reduce the incidence of carcinogen-induced large bowel neoplasms in rodents.
- Aspirin and newer NSAIDs have delayed recurrence of polyps in hereditary polyposis of the colon.
- Colorectal cancer mortality rates in US women have declined since 1940, while rates in men have remained relatively unchanged.
Takeaway
Taking certain pain relief medicines called NSAIDs can help lower the chances of getting colon cancer, especially in women.
Limitations
Consumer surveys are needed to identify the most important therapies contributing to the decrease in colorectal cancer incidence and mortality.
Participant Demographics
Women are noted to have higher rates of headaches, arthritis, and back pains, which may influence their cancer risk.
Want to read the original?
Access the complete publication on the publisher's website